Related Experiment Videos

Rho kinase: an important mediator of atherosclerosis and vascular disease

Qian Zhou1, James K Liao

  • 1Vascular Medicine Research Unit, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Current Pharmaceutical Design
|September 17, 2009
PubMed

Insights

Statins reduce vascular inflammation and atherosclerosis by inhibiting Rho-kinase (ROCK). This cholesterol-independent effect targets ROCK

Area of Science:

  • Cardiovascular Biology
  • Inflammation Research
  • Pharmacology

Background:

  • Atherosclerosis involves inflammation and lipid accumulation.
  • Statins offer cholesterol-independent 'pleiotropic effects' against vascular inflammation.
  • These effects stem from inhibiting isoprenoid synthesis, impacting Rho/Rho-kinase (ROCK) pathways.

Purpose of the Study:

  • To review the role of Rho-kinase (ROCK) in cardiovascular disease.
  • To elucidate how ROCK inhibition by statins impacts vascular inflammation and atherosclerosis.
  • To highlight ROCK's contribution to endothelial dysfunction and related conditions.

Main Methods:

  • Literature review focusing on statin pleiotropic effects.
  • Analysis of the Rho-kinase (ROCK) signaling pathway.
  • Examination of studies linking ROCK activity to cardiovascular pathologies.

Main Results:

  • ROCK inhibition by statins up-regulates endothelial nitric oxide synthase (eNOS).
  • Decreased vascular inflammation and reduced atherosclerotic plaque formation observed.
  • ROCK pathway is implicated in endothelial dysfunction, ischemia, and metabolic syndrome.

Conclusions:

  • ROCK pathway inhibition is a key mechanism for statin's anti-atherosclerotic effects.
  • Targeting ROCK offers therapeutic potential for cardiovascular diseases.
  • Understanding ROCK's role is crucial for managing vascular inflammation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...